Skip to main content
. Author manuscript; available in PMC: 2015 Jun 29.
Published in final edited form as: J Biomol Struct Dyn. 2014 Jul 11;33(5):1140–1152. doi: 10.1080/07391102.2014.932310

Figure 5.

Figure 5

Side ((A) on left) and top ((B) on right) view of the known agonist docked to the rhodopsin-based homology model. Agonist 3D geometry optimization has been performed by Gaussian HF/6-31G* basis (Blue) and Marvin Chemaxon MM force field (Red) structure.